Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09LSY
|
||||
Former ID |
DIB014513
|
||||
Drug Name |
EDP-322
|
||||
Synonyms |
EP-16322; Antibacterial (oral, Gram-positive infections), Enanta; EDP-MRSA-1 (oral), Enanta
|
||||
Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Phase 1 | [548796] | ||
Company |
Enanta Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(nc(cs1)N)c1ccc(nc1)CO/N=C/1\CO[C@H]2[C@](C)(O)[C@H](<br />OC(=O)[C@](F)(C)C(=O)[C@@H]([C@H]([C@](OC1)(C[C@H](/C(=<br/>N\C(=O)CC)/[C@@H]2C)C)C)O[C@H]1[C@@H]([C@H](C[C@H](O1)C<br />)N(C)C)O)C)CC
|
||||
Target and Pathway | |||||
Target(s) | Multidrug resistance protein 1 | Target Info | Inhibitor | [532939] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.